Search results for "Stroke"
Home-based INR monitoring associated with fewer adverse events
An industry-funded, claims-based analysis found that patients on warfarin who tested their international normalized ratio (INR) at home had lower rates of stroke, thromboembolism, and major bleeding than patients whose INRs were measured at physicians' offices or in laboratories.
https://immattersacp.org/weekly/archives/2024/01/02/4.htm
2 Jan 2024
Sorting out vertigo
A shift in diagnostic approach for vertigo involves asking about the timing and triggers for episodes rather than a description of symptoms.
https://immattersacp.org/archives/2024/01/sorting-out-vertigo.htm
1 Jan 2024
Welcome to I.M. Matters from ACP
This issue announces our new name and includes lead stories on vertigo and grateful patient fundraising.
https://immattersacp.org/archives/2024/01/welcome-to-im-matters-from-acp.htm
1 Jan 2024
Afib guideline updates diagnosis, management strategies
An updated guideline from cardiology societies places new emphasis on lifestyle and risk factor modification in patients with atrial fibrillation and risk for recurrence when afib occurs after surgery, among other changes.
https://immattersacp.org/weekly/archives/2023/12/12/4.htm
12 Dec 2023
Patch monitor screening for atrial fibrillation may be cost-effective in high-risk patients
Wearing patch monitors for two weeks of atrial fibrillation screening provided economic value in gained quality-adjusted life-years for high-risk older patients, according to a new analysis of a randomized trial.
https://immattersacp.org/weekly/archives/2023/11/07/4.htm
7 Nov 2023
MKSAP Quiz: Dyspnea, exertional syncope
A 75-year-old man is evaluated for dyspnea and an episode of exertional syncope. He is diagnosed on clinical examination with aortic stenosis. Following an ECG, echocardiogram, and other data, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2023/10/31/3.htm
31 Oct 2023
Rosuvastatin, atorvastatin compared on effectiveness, safety in industry-funded trial
Analysis of a randomized trial in South Korea found that patients randomized to rosuvastatin developed type 2 diabetes requiring medication at a rate of 7.2%, compared to 5.3% among those given atorvastatin.
https://immattersacp.org/weekly/archives/2023/10/24/4.htm
24 Oct 2023
Combating the crisis of loneliness
While the COVID-19 pandemic put a spotlight on loneliness, social engagement with friends and family has been falling for the past two decades as feelings of social isolation have increased.
https://immattersacp.org/archives/2023/10/combating-the-crisis-of-loneliness.htm
1 Oct 2023
Higher aspirin dose no more effective for CV prevention in high-risk patients with diabetes
A subgroup analysis of a randomized trial found that patients with diabetes and atherosclerotic cardiovascular disease had similar outcomes whether they took 81 mg or 325 mg of aspirin daily.
https://immattersacp.org/weekly/archives/2023/09/26/2.htm
26 Sep 2023
Subclinical eGFR associated with cardiovascular disease in younger patients
A retrospective cohort study in Canada found that the relative risk for major cardiovascular events with or without heart failure increased in adults ages 18 to 39 years with an eGFR below 80 mL/min/1.73 m2.
https://immattersacp.org/weekly/archives/2023/09/19/2.htm
19 Sep 2023